New Cancer Medication Launched
The Government continues work to strengthen the country’s cancer care system through strategic partnerships with international entities. On August 26 of this year, the Government signed a contract with global leader in diagnostic and pharmaceutical products, Roche, to market Herceptin Subcutaneous (SC), an agent commonly used in the treatment of early stage Human Epidermal Growth Factor Receptor (HER) 2 Positive...






